A Single-arm Phase II Trial to Evaluate Serum Estradiol Levels in Patients With Breast Cancer Treated With Vaginal Estrogen, Estring
Phase of Trial: Phase II
Latest Information Update: 22 May 2019
Price : $35 *
At a glance
- Drugs Estradiol (Primary)
- Indications Genitourinary disorders
- Focus Pharmacodynamics
- 17 May 2019 Status changed from active, no longer recruiting to completed.
- 31 Aug 2018 Biomarkers information updated
- 24 Apr 2018 Planned End Date changed from 30 Jun 2018 to 30 Jun 2019.